# Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

> **NCT00463515** · PHASE2 · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 77 (—)

## Conditions studied

- Non-Small-Cell-Lung Cancer

## Interventions

- **DRUG:** carboplatin/gemcitabine
- **PROCEDURE:** cisplatin/radiation therapy

## Key facts

- **NCT ID:** NCT00463515
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 77 (—)
- **Last updated:** 2013-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463515, "Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00463515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*